Search results
Reduced Breast Cancer Mortality: Screen, Prevent, Treat
Medscape· 3 days agoDr Maurie Markman discusses results from a modeling study investigating the reduction in breast...
Beyond weight loss: Bariatric surgery may reduce cancer risk
Lexington Herald-Leader· 7 hours agoWhen you think about obesity, you may not connect it to cancer. Among those are endometrial, ovarian, colon, liver, pancreatic and postmenopausal breast cancers, which together ...
I got a boob job so my husband wouldn't leave me…instead it nearly killed me
The US Sun· 21 hours agoThe plunging neckline of her asymmetrical white gown showed off her 34DD implants to perfection —...
Mammogram guideline sparks debate among breast cancer experts
Newsday· 5 days agoHealth experts agree that mammograms can save lives, but they don’t always agree on how often women...
Opinion: What you need to know about breast cancer screening guidelines
Stamford Advocate· 3 days agoYou may have seen the recent news about the breast cancer screening guidelines. It is good news for...
Criticism leads to the removal of a controversial billboard about breast augmentation in Madrid
Hardwood Paroxysm· 6 days agoControversy...A popular campaign to demand its withdrawal And he finally succeeded. This entity, which fights to “stop the sexualization of breasts, or rather appearance,” ...
Fredericton woman with terminal ovarian cancer warns others of risks
CBC via Yahoo News· 5 days agoThe "cancer that whispers" is what ovarian cancer is often called. That's because of its often...
Atossa Genetics stock PT raised on promising study and lower operating expenses By Investing.com
Investing.com· 2 days agoThe revision follows Atossa's announcement of its first-quarter 2024 financial results and updates...
How Blac Chyna Found Angela White Again in Her Transformation Journey - E! Online
E! Online· 5 days agoAs Blac Chyna, real name Angela White, celebrates her 36th birthday, look back at her personal and...
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 3 days agoPresented data from EVANGELINE study showing 100% disease control rate at 24-weeks Initiated study evaluating (Z)-endoxifen in combination with abemaciclib (VERZENIO®)Ended first quarter 2024 ...